Presentation Information

[O15-04]Safety and immunogenecity of mRNA-1345 vaccine in Japanese older adults aged ≧ 60 years

*Osamu Kogawara1, Lauren Wilson2, Caroline Reuter2, Shraddha Mehta2, Archana Kapoor2, Lan Lan2, Honghong Zhou2, Jaya Goswami2, Frances Priddy2, Rituparna Das2 (1. Moderna Japan Co., Ltd., 2. Moderna, Inc.)

Password required to view